These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11467800)

  • 41. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
    Chang CK; Tan HF; Tseng HF; Lin CC
    Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroepidemiology of varicella-zoster virus in Korea.
    Lee H; Cho HK; Kim KH
    J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The epidemiology of Varicella Zoster Virus infection in Italy.
    Gabutti G; Rota MC; Guido M; De Donno A; Bella A; Ciofi degli Atti ML; Crovari P;
    BMC Public Health; 2008 Oct; 8():372. PubMed ID: 18954432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Varicella zoster and fever rash surveillance in Lao People's Democratic Republic.
    Nouanthong P; Hübschen JM; Billamay S; Mongkhoune S; Vilivong K; Khounvisith V; Sinner R; Grandadam M; Phonekeo D; Black AP; Muller CP
    BMC Infect Dis; 2019 May; 19(1):392. PubMed ID: 31068140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Seroepidemiologic survey on varicella-zoster infection in the Province of Lecce].
    De Donno A; Guido M; Maiorano M; Zizza A; Tronci A; Gabutti G
    Ann Ig; 2001; 13(2):93-100. PubMed ID: 11414108
    [No Abstract]   [Full Text] [Related]  

  • 46. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.
    Struewing JP; Hyams KC; Tueller JE; Gray GC
    Am J Public Health; 1993 Dec; 83(12):1717-20. PubMed ID: 8259801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia.
    Bartoloni A; Bartalesi F; Roselli M; Mantella A; Dini F; Carballo ES; Barron VP; Paradisi F
    Trop Med Int Health; 2002 Jun; 7(6):512-7. PubMed ID: 12031073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cost-saving potential of prevaccination antibody tests when implementing a mass immunization program.
    Memish ZA; Oni GA; Bannatyne RM; Qasem L
    Mil Med; 2001 Jan; 166(1):11-3. PubMed ID: 11197089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
    Pozza F; Piovesan C; Russo F; Bella A; Pezzotti P; Emberti Gialloreti L
    Vaccine; 2011 Nov; 29(51):9480-7. PubMed ID: 22015389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.
    Perez-Farinos N; Garcia-Comas L; Ramirez-Fernandez R; Sanz JC; Barranco D; Garcia-Fernandez C; Ordobas M
    Cent Eur J Public Health; 2008 Mar; 16(1):41-4. PubMed ID: 18459480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Has VZV epidemiology changed in Italy? Results of a seroprevalence study.
    De Donno A; Kuhdari P; Guido M; Rota MC; Bella A; Brignole G; Lupi S; Idolo A; Stefanati A; Del Manso M; Gabutti G;
    Hum Vaccin Immunother; 2017 Feb; 13(2):385-390. PubMed ID: 28027004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005.
    Ueno-Yamamoto K; Tanaka-Taya K; Satoh H; Araki K; Kaku M; Okabe N
    Pediatr Infect Dis J; 2010 Jul; 29(7):667-9. PubMed ID: 20228693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
    Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
    Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes.
    Salleras L; Domínguez A; Vidal J; Plans P; Salleras M; Taberner JL
    Vaccine; 2000 Sep; 19(2-3):183-8. PubMed ID: 10930671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modelling the impact of immunization on the epidemiology of varicella zoster virus.
    Brisson M; Edmunds WJ; Gay NJ; Law B; De Serres G
    Epidemiol Infect; 2000 Dec; 125(3):651-69. PubMed ID: 11218215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroepidemiology of varicella in Hangzhou, China in the vaccine era.
    Xu Y; Liu S; Che X; Liu Y; Zhang X; Du J; Zhang X; Wang J; Xu E
    Hum Vaccin Immunother; 2018; 14(10):2464-2471. PubMed ID: 30019992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate.
    O'Grady KA; Merianos A; Patel M; Gilbert L
    Trop Med Int Health; 2000 Oct; 5(10):732-6. PubMed ID: 11044268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.